Skip to main content Skip to footer
Investor Relations
Back to OpusGTX.com
Opus Genetics, Inc. IR Overview
  • Overview
  • Press Releases
  • Events
  • Company Info
    • Overview
    • Management Team
    • Presentations
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote and Chart
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Investor Tools
    • Email Alerts
    • Contacts
    • RSS News Feed
  • Back to OpusGTX.com

Press Releases

Mar 19, 2025 3:56 pm EDT
Opus Genetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Mar 5, 2025 8:00 am EST
Opus Genetics Announces Presentations at Association for Research in Vision and Ophthalmology (ARVO) 2025 Meeting
Feb 26, 2025 8:00 am EST
Opus Genetics Announces FDA Fast Track and Enrollment Updates for Phentolamine Ophthalmic Solution 0.75% Programs
Feb 18, 2025 7:30 am EST
Opus Genetics Announces Updates on OPGx-LCA5 Clinical Program
Dec 19, 2024 8:00 am EST
Opus Genetics Receives FDA Agreement Under Special Protocol Assessment for Phase 3 Trial of APX3330 in Diabetic Retinopathy
Dec 3, 2024 8:00 am EST
Opus Genetics to Host Virtual KOL Event on OPGx-LCA5 as a Treatment for LCA5-Associated Inherited Retinal Disease on December 11, 2024
Nov 12, 2024 8:00 am EST
Opus Genetics Announces Financial Results for Third Quarter 2024 and Provides Corporate Update
Nov 12, 2024 7:59 am EST
Opus Genetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Oct 22, 2024 4:05 pm EDT
Ocuphire Pharma Announces Acquisition of Opus Genetics
Sep 30, 2024 8:00 am EDT
Ocuphire Pharma Announces Publication of Full Phase 3 Results of Phentolamine Ophthalmic Solution 0.75% for Pharmacologically-Induced Mydriasis in Ophthalmology
  • Previous Pagearrow_back
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • …
  • Page 19
  • Next Pagearrow_forward
rss_feed News RSS
  • location_cityCompany Profile
  • contact_pageContacts
  • rss_feedRSS News Feed
  • account_treeSitemap
©2025 Opus Genetics, Inc. All Rights Reserved.
  • Privacy Policy
  • Disclaimer
  • Sitemap
  • Accessibility Statement